Anthony Martinelli

Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com, and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. You can reach Anthony at Info@TheMarijuanaHerald.com.

Author's posts

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

According to an update provided today by the Florida Division of Elections, Smart & Safe Florida has submitted 675,714 verified signatures for their initiative to legalize cannabis. This is nearly 80% of the 880,062 required by the February deadline to make the 2026 ballot.

Continue reading

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Ohio’s legal marijuana market has rapidly grown into one of the nation’s most robust, with new state data showing over $1.2 billion in total sales since the launch of the adult-use market in August 2024. Since recreational sales launched in August 2024, adult-use revenue has reached $923,600,777. Combined with $331,622,009 in medical sales over that …

Continue reading

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

A laboratory study in the Journal of Drug Delivery Science and Technology finds that while both a commercial vape pen and a CE-marked medical device can generate respirable marijuana aerosols, only the medical device delivered reliably consistent doses. Researchers at Université Jean Monnet Saint-Étienne compared a medical inhalation device (BIKY Breathe) with a common retail …

Continue reading

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

Arkansas’ medical marijuana program continues to expand, with 112,760 patients now registered as of November 1, 2025, according to new figures released by the Department of Health. The program was established after voters passed the Arkansas Medical Marijuana Amendment (Issue 6) in November 2016. The measure legalized medical marijuana for patients with qualifying conditions and …

Continue reading

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

New Mexico’s legal marijuana industry generated $47 million in sales during October, bringing the state’s total for 2025 to roughly $475 million. Of the October total, $36.6 million came from adult-use purchases and $10.4 million from medical sales, according to data from the Cannabis Control Division. Retailers recorded 1.2 million total transactions during the month, …

Continue reading

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Curaleaf Holdings reported $320 million in revenue for the third quarter of 2025, up 2% from the previous quarter. The company’s overseas operations generated $46 million—up 56% year-over-year—helping offset domestic price compression that has challenged the broader marijuana industry.

Continue reading

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Aurora Cannabis Inc. reported fiscal second-quarter 2026 revenue of $90.4 million, an 11% increase year-over-year, driven largely by record global medical marijuana sales. The Edmonton-based company said medical cannabis net revenue rose 15% to $70.5 million, accounting for 78% of total revenue. International medical revenue grew 22% to $42.7 million, with strong performance in markets …

Continue reading

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Trulieve Cannabis Corp. reported third-quarter revenue of $288 million, with 94% generated from retail operations and a gross margin of 59%, underscoring continued operational strength and cash flow discipline. The company, which operates 232 dispensaries across the U.S., said it sold more than 12.5 million branded products during the quarter, a 7% increase from the …

Continue reading

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted treatments, according to a new study by researchers from Rangsit University and Mahidol University. The study was published in the Journal of Cannabis Research and indexed by the U.S. National Library of Medicine.

Continue reading

D.C. Regulators Propose New Rules Restricting Non-Cannabis Sales at Medical Cannabis Retailers

The Alcoholic Beverage and Cannabis Board (ABCA) has announced proposed rule changes that would significantly limit what non-cannabis products medical marijuana retailers can sell or serve in the District of Columbia. The proposal, adopted unanimously by the Board, attempts to clarify long-standing ambiguities surrounding non-cannabis retail activity while addressing concerns about youth access and community …

Continue reading